Cardiff Oncology at Noble Capital: Promising Results for Onvansertib
PositiveFinancial Markets

Cardiff Oncology recently presented promising results for its drug Onvansertib at the Noble Capital conference. This development is significant as it showcases the potential of Onvansertib in treating various cancers, which could lead to improved patient outcomes and new treatment options in the oncology field.
— Curated by the World Pulse Now AI Editorial System